Page results
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
-
Once you have completed treatment for cancer at UCLH you will enter a period of follow-up care. Follow-up is an important way of monitoring your health.
-
This page explains how our plasma cell multidisciplinary team (MDT) will support you during treatmen
-
Information about incentive spirometry (IS) for adults with sickle cell disorder.
-
Information about community sickle cell and thalassaemia services provided via UCLH.
-
Support patients in hospital this Christmas and the staff looking after them by donating to our UCLH Charity Gift of Giving Appeal.
-
A guide to choosing diabetes technology for UCLH patients
-
Our cancer team monitors all urgent, two-week wait, suspected cancer referrals from GPs. All appointments are carefully and systematically monitored to ensure a speedy and efficient patient journey from diagnosis to treatment or discharge.
-
Dr Riaz' clinical practice includes a wide range of radionuclide diagnostic and therapeutic procedures, including conventional Nuclear Medicine imaging, oncologic and non-oncological PET imaging, cardiac PET imaging, and radionuclide therapies for thyroid cancer, prostate cancer and other rare cancers.
-
This page explains who you will meet and what to expect at your appointment with the adolescent gynaecology team at UCLH.
File results
-
FOI/2023/0916 - Gender options on patient forms
-
FOI/2023/0917 - Patient Initiated Digital Mutual Aid System (PIDMAS)
-
FOI/2023/0921 - Trust provider for sexual health platform
-
FOI/2023/0923 - Proton Beam Therapy treatments
-
FOI/2023/0925 - Stereotactic radiosurgery treatment/ gamma knife treatment
-
FOI/2023/0926 - Electronic Patient Record Supplier (EPR) contract
-
FOI/2023/0930 - Patient deaths while on waiting list 2018-2023
-
FOI/2023/0931 - Trust surgical and equipment drape usage in theatre departments
-
FOI/2023/0934 - Treatment for Haemophilia B and Von Willebrand disease
-
FOI/2023/0936 - Policy and Procedure management at Trust